Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Peijia Medical Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Operating profit has grown by an annual rate 6.09% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -361.58
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -7.65%, its profits have risen by 17.3%
3
Below par performance in long term as well as near term
- Along with generating -7.65% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Peijia Medical Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Peijia Medical Ltd.
-7.65%
1.00
45.26%
Hang Seng Hong Kong
8.76%
0.45
19.63%
Quality key factors
Factor
Value
Sales Growth (5y)
68.42%
EBIT Growth (5y)
6.09%
EBIT to Interest (avg)
-361.58
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
0.16
Tax Ratio
3.11%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.82
EV to EBIT
-14.75
EV to EBITDA
-21.06
EV to Capital Employed
1.95
EV to Sales
4.98
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-13.24%
ROE (Latest)
-10.60%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Movement
12What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD 16.39 MM
NET PROFIT(HY)
Higher at HKD -156.41 MM
ROCE(HY)
Highest at -10.5%
INVENTORY TURNOVER RATIO(HY)
Highest at 1.66 times
DEBTORS TURNOVER RATIO(HY)
Highest at 9.01 times
NET SALES(Q)
Highest at HKD 393.56 MM
-5What is not working for the Company
INTEREST(HY)
At HKD 6.48 MM has Grown at 29.74%
DEBT-EQUITY RATIO
(HY)
Highest at -8.36 %
RAW MATERIAL COST(Y)
Grown by 5.27% (YoY
Here's what is working for Peijia Medical Ltd.
Net Sales
Highest at HKD 393.56 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (HKD MM)
Net Profit
Higher at HKD -156.41 MM
than preceding 12 month period ended Dec 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (HKD MM)
Inventory Turnover Ratio
Highest at 1.66 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 9.01 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Operating Cash Flow
Highest at HKD 16.39 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Depreciation
Highest at HKD 36.93 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Here's what is not working for Peijia Medical Ltd.
Interest
At HKD 6.48 MM has Grown at 29.74%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Debt-Equity Ratio
Highest at -8.36 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 5.27% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






